Abstract:Advances in pediatric and obstetric surgery have resulted in an increase in the duration and complexity of procedures requiring anesthesia. It has been reported that anesthetic drugs cause widespread and dose-dependent apoptosis in the developing rat brain. The similarity of the physiology, pharmacology, metabolism, and reproductive systems of the nonhuman primate to that of the human, especially during pregnancy, make the monkey an exceptionally good animal model for assessing potential neurotoxic effects of anesthetics. The window of vulnerability to these neuronal effects of pediatric anesthetics is restricted to the period of rapid synaptogenesis, also known as the brain growth spurt period. To minimize the risks to children resulting from the use of anesthesia, the following questions should be addressed: 1. What is the relationship between exposure and brain cell loss for drugs commonly used in the practice of pediatric anesthesia (inhaled anesthetics, midazolam, ketamine, and nitrous oxide)? 2. Are there "class effects," or does each drug need to be considered independently? 3. Are there important interactions among the drugs used as anesthetics contributing to the risk of brain cell death? 4. What is the likely period of human vulnerability? Pharmacogenomic/system biology approaches have great potential for helping to advance the understanding of brain-related biological processes, including neuronal plasticity and neurotoxicity. Because of the complexity and temporal features of how developmental neurotoxicity is manifested, pharmacogenomic/systems biology approaches may prove to be useful tools for enhancing our understanding of the biological processes induced by anesthetics. Therefore, the main purpose of this review is to describe the application of these approaches and models, as well as protection strategies, especially as regards the issue of anesthetic-induced neuronal cell death during development. Much of the discussion that follows is based on experiments conducted with ketamine. This is due in part to the use of ketamine in the early studies and the volume of preclinical experimental work performed with this drug, as well as its use in anesthetic studies in developing rodents and nonhuman primates. Although ketamine use in pediatric anesthesia is relatively limited, the findings of the studies are sufficiently strong to merit concern about the N-methyl-d-aspartate antagonist drugs as a class. Our focus on ketamine should not be construed as implying that the risk of neurodegeneration with ketamine is greater, or less, than with other anesthetics. We are simply describing the effects where we have the most preclinical data.

Ketamine Inhibits Neuronal Differentiation by Regulating Brain-Derived Neurotrophic Factor (BDNF) Signaling

Ketamine Induces Toxicity in Human Neurons Differentiated from Embryonic Stem Cells Via Mitochondrial Apoptosis Pathway

Ketamine Promotes the Neural Differentiation of Mouse Embryonic Stem Cells by Activating Mtor

Ketamine Enhances Human Neural Stem Cell Proliferation and Induces Neuronal Apoptosis Via Reactive Oxygen Species–Mediated Mitochondrial Pathway

Ketamine modulates neural stem cell differentiation by regulating TRPC3 expression through the GSK3β/β-catenin pathway

Effects of Ketamine on Monoamine Neurotransmitters and Gaba in Embryonic Neurocytes from Fetal Rat

Ketamine-induced Neuronal Damage and Altered N-methyl-D-aspartate Receptor Function in Rat Primary Forebrain Culture.

Repeated Ketamine Anesthesia during the Neonatal Period Impairs Hippocampal Neurogenesis and Long-Term Neurocognitive Function by Inhibiting Mfn2-Mediated Mitochondrial Fusion in Neural Stem Cells

Long-term neurocognitive dysfunction in offspring via NGF/ ERK/CREB signaling pathway caused by ketamine exposure during the second trimester of pregnancy in rats

Ketamine exerts dual effects on the apoptosis of primary cultured hippocampal neurons from fetal rats in vitro

Neuroprotective Effects of Dexmedetomidine on the Ketamine-Induced Disruption of the Proliferation and Differentiation of Developing Neural Stem Cells in the Subventricular Zone

Strategies and Experimental Models for Evaluating Anesthetics: Effects on the Developing Nervous System

Prenatal Exposure to General Anesthesia Drug Esketamine Impaired Neurobehavior in Offspring

Effects of Ketamine and Midazolam on Morphology of Dendritic Spines in Hippocampal Ca1 Region of Neonatal Mice

Dual Effects of Ketamine

Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP mice

Neonatal Exposure to Ketamine Disrupts Developmental Synapse Unsilencing and Predisposes Adult Mice for Stressor-Evoked Anxiety

Ketamine-induced Apoptosis in the Mouse Cerebral Cortex Follows Similar Characteristic of Physiological Apoptosis and Can Be Regulated by Neuronal Activity

Mechanisms of Propofol Attenuation of Ketamine-Induced Neonatal Brain Injury

Retraction Note: Ketamine Exerts Neurotoxic Effects on the Offspring of Pregnant Rats Via the Wnt/β-catenin Pathway

Ketamine administered to pregnant rats in the second trimester causes long-lasting behavioral disorders in offspring